Qsemble Capital Management, LP
Source: SEC Form 13F · as of Mar 2026Qsemble Capital Management, LP holds 23 biotech & pharma companies tracked by BioSniper, totaling $85.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
23
Total value held
$85.2M
| Company | Shares | Value |
|---|---|---|
| GMOptec International, Inc. | 156,019 | $11.6M |
| AMGNAMGEN INC | 32,165 | $11.3M |
| LLYELI LILLY & Co | 9,538 | $8.8M |
| ABTABBOTT LABORATORIES | 79,632 | $8.2M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 25,966 | $7.0M |
| PFEPFIZER INC | 211,117 | $5.9M |
| GILDGILEAD SCIENCES, INC. | 40,564 | $5.7M |
| BMYBRISTOL MYERS SQUIBB CO | 76,793 | $4.7M |
| DVADaVita Inc. | 23,257 | $3.6M |
| MCKMcKesson Corporation | 3,988 | $3.5M |
| ELVElevance Health Inc. | 10,014 | $2.9M |
| BBIOBridgeBio Pharma, Inc. | 36,570 | $2.7M |
| VKTXViking Therapeutics, Inc. | 80,278 | $2.6M |
| IONSIONIS PHARMACEUTICALS INC | 25,758 | $1.9M |
| INCYIncyte Corp. | 10,549 | $993K |
| HALOHALOZYME THERAPEUTICS, INC. | 15,064 | $974K |
| UTHRUNITED THERAPEUTICS Corp | 1,051 | $623K |
| CYTKCYTOKINETICS INC | 8,810 | $581K |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 2,645 | $456K |
| GEHCGE HealthCare Technologies Inc. | 6,024 | $429K |
| QGENQIAGEN N.V. | 7,513 | $301K |
| JAZZJazz Pharmaceuticals plc | 1,217 | $230K |
| QUREuniQure N.V. | 11,643 | $190K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.